These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14625567)

  • 1. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2).
    Jourdier TM; Moste C; Bonnet MC; Delisle F; Tafani JP; Devauchelle P; Tartaglia J; Moingeon P
    Gene Ther; 2003 Dec; 10(26):2126-32. PubMed ID: 14625567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
    Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
    Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of canarypox (ALVAC) vectors in human and veterinary vaccination.
    Taylor J; Tartaglia J; Rivière M; Duret C; Languet B; Chappuis G; Paoletti E
    Dev Biol Stand; 1994; 82():131-5. PubMed ID: 7958467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant cancer vaccines based on viral vectors.
    Moingeon P
    Dev Biol (Basel); 2004; 116():117-22; discussion 133-43. PubMed ID: 15603188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform.
    Poulet H; Minke J; Pardo MC; Juillard V; Nordgren B; Audonnet JC
    Vaccine; 2007 Jul; 25(30):5606-12. PubMed ID: 17227690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study.
    Jahnke A; Hirschberger J; Fischer C; Brill T; Köstlin R; Plank C; Küchenhoff H; Krieger S; Kamenica K; Schillinger U
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):599-606. PubMed ID: 18045346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma.
    Triozzi PL; Allen KO; Carlisle RR; Craig M; LoBuglio AF; Conry RM
    Clin Cancer Res; 2005 Jun; 11(11):4168-75. PubMed ID: 15930353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.
    Karaca K; Bowen R; Austgen LE; Teehee M; Siger L; Grosenbaugh D; Loosemore L; Audonnet JC; Nordgren R; Minke JM
    Vaccine; 2005 May; 23(29):3808-13. PubMed ID: 15893618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
    El Bakkouri K; Servais C; Clément N; Cheong SC; Franssen JD; Velu T; Brandenburger A
    J Gene Med; 2005 Feb; 7(2):189-97. PubMed ID: 15515141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes.
    Trakatelli M; Toungouz M; Lambermont M; Heenen M; Velu T; Bruyns C
    Cancer Gene Ther; 2005 Jun; 12(6):552-9. PubMed ID: 15665821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage.
    Yu Q; Jones B; Hu N; Chang H; Ahmad S; Liu J; Parrington M; Ostrowski M
    Vaccine; 2006 Sep; 24(40-41):6376-91. PubMed ID: 16859816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
    Grosenbaugh DA; Leard T; Pardo MC
    J Am Vet Med Assoc; 2006 Mar; 228(5):726-7. PubMed ID: 16506935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
    Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-associated feline sarcomas.
    Brearley MJ
    Vet Rec; 2001 May; 148(18):580. PubMed ID: 11370891
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat.
    Bachman D; Cockerell GL; de Noronha F; Rapp HJ
    Am J Vet Res; 1982 Mar; 43(3):475-80. PubMed ID: 6280529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.